MacroGenics
MGNX
#9151
Rank
โ‚ฌ97.65 M
Marketcap
1,54ย โ‚ฌ
Share price
-5.18%
Change (1 day)
-47.27%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: โ‚ฌ97.65 Million

As of February 2026 MacroGenics has a market cap of โ‚ฌ97.65 Million. This makes MacroGenics the world's 9151th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ97.65 M12.64%
2025โ‚ฌ86.69 M-55.5%
2024โ‚ฌ0.19 B-63.91%
2023โ‚ฌ0.53 B40.37%
2022โ‚ฌ0.38 B-55.74%
2021โ‚ฌ0.86 B-16.88%
2020โ‚ฌ1.04 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of MacroGenics was reported to be:

โ‚ฌ97.65 Million
by Nasdaq info icon info icon
โ‚ฌ97.65 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ126.81 B 129,760.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ784.34 B 803,057.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ155.30 B 158,927.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ148.58 B 152,049.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ232.35 B 237,826.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ94.54 B 96,708.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.72 B 645.79%๐Ÿ‡บ๐Ÿ‡ธ USA